19 November 2017
News and Views
Links and Services
Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use, reports this month's Annals of Internal Medicine.
Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affe
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors